UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047543
Receipt number R000054222
Scientific Title Study of the preventive effect on frailty by low doses continuous intake of polyamine
Date of disclosure of the study information 2022/04/21
Last modified on 2022/10/26 09:47:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the preventive effect on frailty by low doses continuous intake of polyamine

Acronym

Study of the preventive effect on frailty by low doses continuous intake of polyamine

Scientific Title

Study of the preventive effect on frailty by low doses continuous intake of polyamine

Scientific Title:Acronym

Study of the preventive effect on frailty by low doses continuous intake of polyamine

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the preventive effect on frailty by low doses intake of polyamine for 12 weeks in Japanese adult men (50 to 64 years old).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skeletal muscle mass

Key secondary outcomes

Urine polyamine
Urine deoxypyridinoline
Muscle mass (Right arm, Left arm,Truncus, Right leg, Left leg)
Grip strength
Back muscle strength
Leg strength
Blood pressure (Systolic and Diastolic)
Questionnaire regarding cognitive function


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingest 2 tablets of the test food (polyamine-containing capsules) each after breakfast, lunch and dinner (total 6 tablets: 1,800 mg) daily for 12 weeks.

Interventions/Control_2

Ingest 2 tablets of the placebo food each after breakfast, lunch and dinner (total 6 tablets: 1,800 mg) daily for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

65 years-old >

Gender

Male

Key inclusion criteria

1.Persons who received sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document

2.Japanese men who are 50 years old or more and under 65 years old

Key exclusion criteria

1.Persons who have any chronic illnesses with medication and who have any serious disease histories

2.Persons who have any allergies to the ingredients used in the test food (especially persons who have allergies to wheat)

3.Persons who regularly take large amounts of polyamine-containing supplements

4.Persons who regularly take soy foods

5.Persons who regularly use medicines or foods with health claims (foods for specified health use, foods with functional claims and foods with nutritional claims) etc., that may affect skeletal muscle mass.

6.Persons who have participated in other tests within the past one month before the start of test, or those who intend to participate in another exam after consenting to the exam

7.Persons who were judged as inappropriate for study participant by the principal investigator

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Kosei
Middle name
Last name Nishikawa

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Email

nishikawa@hc-sys.jp


Public contact

Name of contact person

1st name Kosei
Middle name
Last name Nishikawa

Organization

Healthcare Systems Co., Ltd.

Division name

Clinical Research Department

Zip code

105-0004

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

TEL

03-6809-2722

Homepage URL


Email

nishikawa@hc-sys.jp


Sponsor or person

Institute

Healthcare Systems Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

TOYOBO Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

Tel

03-6809-2722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

29

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 04 Month 03 Day

Date of IRB

2022 Year 04 Month 04 Day

Anticipated trial start date

2022 Year 04 Month 23 Day

Last follow-up date

2022 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 21 Day

Last modified on

2022 Year 10 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054222